133 related articles for article (PubMed ID: 33821961)
21. Identification of novel fusion transcripts in multiple myeloma.
Lin M; Lee PL; Chiu L; Chua C; Ban KHK; Lin AHF; Chan ZL; Chung TH; Yan B; Chng WJ
J Clin Pathol; 2018 Aug; 71(8):708-712. PubMed ID: 29453220
[TBL] [Abstract][Full Text] [Related]
22. Circulating microRNA expressions can predict the outcome of lenalidomide plus low-dose dexamethasone treatment in patients with refractory/relapsed multiple myeloma.
Jung SH; Lee SE; Lee M; Kim SH; Yim SH; Kim TW; Min CK; Chung YJ
Haematologica; 2017 Nov; 102(11):e456-e459. PubMed ID: 28775122
[No Abstract] [Full Text] [Related]
23. Strategies in treating newly diagnosed or untreated multiple myeloma patients. From the Multiple Myeloma Research Foundation.
Weber DM
Oncology (Williston Park); 2003 Jun; 17(6):765-7. PubMed ID: 12846120
[TBL] [Abstract][Full Text] [Related]
24. Survival prediction and treatment optimization of multiple myeloma patients using machine-learning models based on clinical and gene expression data.
Mosquera Orgueira A; González Pérez MS; Díaz Arias JÁ; Antelo Rodríguez B; Alonso Vence N; Bendaña López Á; Abuín Blanco A; Bao Pérez L; Peleteiro Raíndo A; Cid López M; Pérez Encinas MM; Bello López JL; Mateos Manteca MV
Leukemia; 2021 Oct; 35(10):2924-2935. PubMed ID: 34007046
[TBL] [Abstract][Full Text] [Related]
25. Developing Cancer Informatics Applications and Tools Using the NCI Genomic Data Commons API.
Wilson S; Fitzsimons M; Ferguson M; Heath A; Jensen M; Miller J; Murphy MW; Porter J; Sahni H; Staudt L; Tang Y; Wang Z; Yu C; Zhang J; Ferretti V; Grossman RL;
Cancer Res; 2017 Nov; 77(21):e15-e18. PubMed ID: 29092930
[TBL] [Abstract][Full Text] [Related]
26. High Expression Levels of Long Noncoding RNA Small Nucleolar RNA Host Gene 18 and Semaphorin 5A Indicate Poor Prognosis in Multiple Myeloma.
Huang LJ; Shen Y; Bai J; Wang FX; Feng YD; Chen HL; Peng Y; Zhang R; Li FM; Zhang PH; Lei XR; Xue F; Ma YP; Hu JS; He AL
Acta Haematol; 2020; 143(3):279-288. PubMed ID: 31597158
[TBL] [Abstract][Full Text] [Related]
27. Analysis of Global Gene Expression Profiles.
Kassambara A; Moreaux J
Methods Mol Biol; 2018; 1792():157-166. PubMed ID: 29797258
[TBL] [Abstract][Full Text] [Related]
28. Construction of a prognosis‑associated long noncoding RNA‑mRNA network for multiple myeloma based on microarray and bioinformatics analysis.
Zhu FX; Wang XT; Ye ZZ; Gan ZP; Lai YR
Mol Med Rep; 2020 Mar; 21(3):999-1010. PubMed ID: 32016443
[TBL] [Abstract][Full Text] [Related]
29. Integrated phosphoproteomics and transcriptional classifiers reveal hidden RAS signaling dynamics in multiple myeloma.
Lin YT; Way GP; Barwick BG; Mariano MC; Marcoulis M; Ferguson ID; Driessen C; Boise LH; Greene CS; Wiita AP
Blood Adv; 2019 Nov; 3(21):3214-3227. PubMed ID: 31698452
[TBL] [Abstract][Full Text] [Related]
30. Identification of differentially expressed genes regulated by methylation in colon cancer based on bioinformatics analysis.
Liang Y; Zhang C; Dai DQ
World J Gastroenterol; 2019 Jul; 25(26):3392-3407. PubMed ID: 31341364
[TBL] [Abstract][Full Text] [Related]
31. Predicting multi-level drug response with gene expression profile in multiple myeloma using hierarchical ordinal regression.
Zhang X; Li B; Han H; Song S; Xu H; Hong Y; Yi N; Zhuang W
BMC Cancer; 2018 May; 18(1):551. PubMed ID: 29747599
[TBL] [Abstract][Full Text] [Related]
32. Clonal evolution after treatment pressure in multiple myeloma: heterogenous genomic aberrations and transcriptomic convergence.
Misund K; Hofste Op Bruinink D; Coward E; Hoogenboezem RM; Rustad EH; Sanders MA; Rye M; Sponaas AM; van der Holt B; Zweegman S; Hovig E; Meza-Zepeda LA; Sundan A; Myklebost O; Sonneveld P; Waage A
Leukemia; 2022 Jul; 36(7):1887-1897. PubMed ID: 35643867
[TBL] [Abstract][Full Text] [Related]
33. [Effect of CXCR4 on the Treatment Response and Prognosis of Carfilzomib in Multiple Myeloma].
Shi YY; Hou Q; Tao H; Tao SD; Chen Y; He ZM; Ding BH; Wang CL; Yu L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Apr; 30(2):455-460. PubMed ID: 35395979
[TBL] [Abstract][Full Text] [Related]
34. Increased Expression of SETDB1 Predicts Poor Prognosis in Multiple Myeloma.
Xiang J; Chen X; Chen M; Hou J
Biomed Res Int; 2022; 2022():3307873. PubMed ID: 35372573
[TBL] [Abstract][Full Text] [Related]
35. Treatment options for older myeloma patients. From the Multiple Myeloma Research Foundation.
Anderson KC; Palumbo A;
Oncology (Williston Park); 2005 Apr; 19(4):447-50. PubMed ID: 15934516
[TBL] [Abstract][Full Text] [Related]
36. Expression Profiles of the Individual Genes Corresponding to the Genes Generated by Cytotoxicity Experiments with Bortezomib in Multiple Myeloma.
Ghasemi M; Alpsoy S; Türk S; Malkan ÜY; Atakan Ş; Haznedaroğlu İC; Güneş G; Gündüz M; Yılmaz B; Etgül S; Aydın S; Aslan T; Sayınalp N; Aksu S; Demiroğlu H; Özcebe OI; Büyükaşık Y; Göker H
Turk J Haematol; 2016 Dec; 33(4):286-292. PubMed ID: 27095044
[TBL] [Abstract][Full Text] [Related]
37. pRRophetic: an R package for prediction of clinical chemotherapeutic response from tumor gene expression levels.
Geeleher P; Cox N; Huang RS
PLoS One; 2014; 9(9):e107468. PubMed ID: 25229481
[TBL] [Abstract][Full Text] [Related]
38. Multiple myeloma immunoglobulin lambda translocations portend poor prognosis.
Barwick BG; Neri P; Bahlis NJ; Nooka AK; Dhodapkar MV; Jaye DL; Hofmeister CC; Kaufman JL; Gupta VA; Auclair D; Keats JJ; Lonial S; Vertino PM; Boise LH
Nat Commun; 2019 Apr; 10(1):1911. PubMed ID: 31015454
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of the Simplified Score to Predict Early Relapse in Multiple Myeloma (S-ERMM) in the MMRF CoMMpass study.
Slade M; Fiala M; Kelley S; Crees ZD; Schroeder MA; Stockerl-Goldstein K; Vij R
Leuk Res; 2023 Apr; 127():107037. PubMed ID: 36801522
[TBL] [Abstract][Full Text] [Related]
40. Panobinostat plus bortezomib and dexamethasone versus placebo plus bortezomib and dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma: a multicentre, randomised, double-blind phase 3 trial.
San-Miguel JF; Hungria VT; Yoon SS; Beksac M; Dimopoulos MA; Elghandour A; Jedrzejczak WW; Günther A; Nakorn TN; Siritanaratkul N; Corradini P; Chuncharunee S; Lee JJ; Schlossman RL; Shelekhova T; Yong K; Tan D; Numbenjapon T; Cavenagh JD; Hou J; LeBlanc R; Nahi H; Qiu L; Salwender H; Pulini S; Moreau P; Warzocha K; White D; Bladé J; Chen W; de la Rubia J; Gimsing P; Lonial S; Kaufman JL; Ocio EM; Veskovski L; Sohn SK; Wang MC; Lee JH; Einsele H; Sopala M; Corrado C; Bengoudifa BR; Binlich F; Richardson PG
Lancet Oncol; 2014 Oct; 15(11):1195-206. PubMed ID: 25242045
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
